Ifrah Financial Services’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-463
| Closed | -$2K | – | 208 |
|
|
2016
Q3 | $2K | Hold |
463
| – | – | ﹤0.01% | 192 |
|
|
2016
Q2 | $4K | Hold |
463
| – | – | ﹤0.01% | 196 |
|
|
2016
Q1 | $5K | Hold |
463
| – | – | ﹤0.01% | 193 |
|
|
2015
Q4 | $7K | Hold |
463
| – | – | ﹤0.01% | 189 |
|
|
2015
Q3 | $8K | Hold |
463
| – | – | ﹤0.01% | 195 |
|
|
2015
Q2 | $9K | Hold |
463
| – | – | ﹤0.01% | 202 |
|
|
2015
Q1 | $9K | Hold |
463
| – | – | ﹤0.01% | 203 |
|
|
2014
Q4 | $14K | Hold |
463
| – | – | 0.01% | 198 |
|
|
2014
Q3 | $16K | Hold |
463
| – | – | 0.01% | 205 |
|
|
2014
Q2 | $21K | Hold |
463
| – | – | 0.01% | 200 |
|
|
2014
Q1 | $23K | Hold |
463
| – | – | 0.01% | 199 |
|
|
2013
Q4 | $17K | Sell |
463
-250
| -35% | -$9.18K | 0.01% | 192 |
|
|
2013
Q3 | $73K | Buy |
+713
| New | +$73K | 0.04% | 106 |
|